Pain Detection
2
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
2
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Latigo BiotherapeuticsCA - Thousand Oaks
2 programspregabalin 300 mgPHASE_11 trial
suzetrigine 100mgPHASE_11 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2024
2025
2026
Latigo Biotherapeuticssuzetrigine 100mg
Latigo Biotherapeuticspregabalin 300 mg
Clinical Trials (2)
Total enrollment: 40 patients across 2 trials
Pharmacodynamic Study of 100mg Suzegtrigine vs Placebo in Healthy Male Adults
Start: Jun 2025Est. completion: Jun 202520 patients
Phase 1Completed
Pharmacodynamic Study of 300mg Pregabalin vs Placebo in Healthy Male Adults
Start: Oct 2024Est. completion: Oct 202420 patients
Phase 1Completed
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.